Valuation: Teva Pharmaceutical Industries Ltd (ADR)

Market Cap 43.66B 37.38B 34.88B 32.01B 60.14B 4,178B 61.33B 414B 161B 2,094B 164B 160B 6,932B P/E 2026 *
49.4x
P/E 2027 * 20.2x
Enterprise Value 55.54B 47.55B 44.37B 40.71B 76.5B 5,314B 78.01B 526B 205B 2,663B 209B 204B 8,818B EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.02x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 43.66B
-2.81%+1.98%+76.96%+127.73% 1,141B
-2.21%+2.50%+50.38%+55.01% 659B
-1.56%+5.25%+26.98%+74.39% 470B
+1.20%+1.72%+42.89%+45.78% 366B
-0.61%+1.72%+25.21%+41.34% 302B
+0.32%+3.30%+2.60%+13.42% 254B
-1.95%+4.22%+46.75%+65.66% 239B
-1.10%-1.12%-14.91%-52.66% 207B
-2.82%+5.57%+21.58%+89.04% 183B
Average -1.05%+4.38%+30.94%+51.08% 424.55B
Weighted average by Cap. -1.41%+4.48%+44.42%+70.86%

Financials

2026 *2027 *
Net sales 16.58B 14.2B 13.25B 12.15B 22.84B 1,587B 23.29B 157B 61.26B 795B 62.26B 60.91B 2,633B 17.3B 14.82B 13.82B 12.68B 23.83B 1,656B 24.3B 164B 63.93B 830B 64.97B 63.56B 2,747B
Net income 1.14B 976M 911M 836M 1.57B 109B 1.6B 10.81B 4.21B 54.69B 4.28B 4.19B 181B 2.34B 2B 1.87B 1.71B 3.22B 224B 3.28B 22.15B 8.63B 112B 8.77B 8.58B 371B
Net Debt 11.88B 10.17B 9.49B 8.71B 16.36B 1,136B 16.68B 113B 43.88B 570B 44.6B 43.63B 1,886B 8.61B 7.37B 6.88B 6.31B 11.86B 824B 12.09B 81.6B 31.81B 413B 32.33B 31.63B 1,367B
Logo Teva Pharmaceutical Industries Ltd (ADR)
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-